We are pleased to inform you that NeuPSIG 2025 has been assessed as compliant by EthicalMedTech through the Conference Vetting System (CVS). The decision is publicly available at www.ethicalmedtech.eu.
The Conference Vetting System (CVS) is an independently managed initiative in the healthcare sector that evaluates the compliance of third-party educational events with the MedTech Europe Code of Ethical Business Practice and the Mecomed Code of Business Practice. The system determines whether member companies of MedTech Europe and Mecomed may support such events through educational grants or commercial activities such as exhibition booths, advertising, or satellite symposia.
Since January 1, 2021, MedTech Europe and the European Federation of Pharmaceutical Industries and Associations (EFPIA) have operated a joint platform to assess Third-Party Organised Educational Events (TPOEs) — the Conference Vetting System (CVS).